Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
For better result, minimum character length is four(4)
Eddingpharm, a China drug in-licensing company, acquired...
Bayer AG will acquire Dihon...
BGI Tech, the contract sequencing division of Shenzhen...
Bayer HealthCare will invest $138...
China is Asia’s number one biopharma cluster,...
Bayer AG closed its $589 million...
China's Waterstone Pharma in-licensed global rights to a...
Bayer AG announced that the CFDA has...
Guizhou Xinbang Pharma acquired Chinese Peptide Company...
Bayer AG completed construction of the...
Upcoming Events
BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here
Register here
Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events
Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here